Announcement on Appointment of Senior Management Member
Filed with SSE · · 2 pages · Chinese
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix
Earlier from Tianjin Pharmaceutical Da Ren Tang
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Branch Obtaining Drug Registration Certificate
- Announcement on Convening the Q3 2025 Performance Briefing
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
Later from Tianjin Pharmaceutical Da Ren Tang
- Announcement on Implementation of Quarterly Dividend Distribution for 2025
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Change of Sponsor Representative for Continuous Supervision
- Special Report on Deposit and Actual Use of Raised Funds
- Announcement on Adding Provisional Proposal at the 2025 Annual General Meeting
Follow Tianjin Pharmaceutical Da Ren Tang into a list and get an email when it puts out news.
Follow Tianjin Pharmaceutical Da Ren Tang